Compound details
Octadecanamide
| Compound ID | CDAMM01965 |
|---|---|
| Common name | Octadecanamide | IUPAC name | octadecanamide |
| Molecular formula | C18H37NO |
| Retention time | 10.49 |
|---|---|
| Adduct | [M+H]+ |
| Actual mz | 284.295 | Theoretical mz | 284.295 |
| Error | 0.44 |
| Ionizaton mode | Positive |
| Instrument type | LC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60 |
| Score | 7.5603 |
| Inchi key | LYRFLYHAGKPMFH-UHFFFAOYSA-N |
|---|---|
| Smiles | O=C(N)CCCCCCCCCCCCCCCCC |
| Superclass | Organic acids and derivatives |
| Class | Carboximidic acids and derivatives |
| Uniprot ID | Gene name | Target name | TTD_ID | Prediction source |
|---|---|---|---|---|
| P07327 | ADH1A | Alcohol dehydrogenase alpha chain | T65570 | SEA |
| P00918 | CA2 | Carbonic anhydrase II | T20401 | SEA |
| Q4U2R8 | SLC22A6 | Solute carrier family 22 member 6 (by homology) | T70680 | SEA |
| P14555 | PLA2G2A | Phospholipase A2 group IIA | T19160 | SEA |
| P04054 | PLA2G1B | Phospholipase A2 group 1B | T31479 | SEA |
| P17612 | PRKACA | cAMP-dependent protein kinase alpha-catalytic subunit | T12808 | SEA |
| P34913 | EPHX2 | Epoxide hydratase | T35734 | SEA |
| P23141 | CES1 | Acyl coenzyme A:cholesterol acyltransferase | T76369 | SEA |
| O00519 | FAAH | Anandamide amidohydrolase | T11754 | SEA |
| Q8NER1 | TRPV1 | Vanilloid receptor | T83193 | SEA |
| P30307 | CDC25C | Dual specificity phosphatase Cdc25C | T40569 | SEA |
| Q6QHF9 | PAOX | Polyamine oxidase | T88699 | SEA |
| P06746 | POLB | DNA polymerase beta (by homology) | T06958 | SEA |
| P10827 | THRA | Thyroid hormone receptor alpha | T79591 | SEA |
| P10828 | THRB | Thyroid hormone receptor beta-1 | T98933 | SEA |
| P37231 | PPARG | Peroxisome proliferator-activated receptor gamma | T58921 | SEA |
| P04035 | HMGCR | HMG-CoA reductase | T53585 | SEA |
| Q99685 | MGLL | Monoglyceride lipase | T18664 | SEA |
| P08842 | STS | Steryl-sulfatase | T33489 | SEA |
| P08263 | GSTA1 | Glutathione S-transferase A1 | T17221 | SEA |
| P30307 | CDC25C | Dual specificity phosphatase Cdc25C | T40569 | SEA |
| Q8TDS5 | OXER1 | Oxoeicosanoid receptor 1 | T68834 | SEA |
| P16109 | SELP | P-selectin | T10965 | SEA |
| Q9Y4D2 | DAGLA | Sn1-specific diacylglycerol lipase alpha | T03150 | SEA |
| Q9H228 | S1PR5 | Sphingosine 1-phosphate receptor Edg-8 | T50089 | SEA |
| P21453 | S1PR1 | Sphingosine 1-phosphate receptor Edg-1 | T13852 | SEA |
| P30307 | CDC25C | Dual specificity phosphatase Cdc25C | T40569 | SEA |
| Q9NRA0 | SPHK2 | Sphingosine kinase 2 | T31989 | SEA |
| Q13822 | ENPP2 | Autotaxin | T63512 | SEA |
| Q9HBW0 | LPAR2 | Lysophosphatidic acid receptor Edg-4 | T39380 | SEA |
| Q99500 | S1PR3 | Sphingosine 1-phosphate receptor Edg-3 | T11241 | SEA |
| P10826 | RARB | Retinoic acid receptor beta | T61657 | SEA |
| P43657 | LPAR6 | Lysophosphatidic acid receptor 6 | T13484 | SEA |
| Q9H1C0 | LPAR5 | Lysophosphatidic acid receptor 5 | T18616 | SEA |
| O95136 | S1PR2 | Sphingosine 1-phosphate receptor Edg-5 | T47888 | SEA |
| O95977 | S1PR4 | Sphingosine 1-phosphate receptor Edg-6 | T17523 | SEA |
| O60906 | SMPD2 | Neutral sphingomyelinase | T57316 | SEA |
| Q9UPC5 | GPR34 | Probable G-protein coupled receptor 34 | T73859 | SEA |
| O00398 | P2RY10 | Putative P2Y purinoceptor 10 | T00488 | SEA |
| Q9BXC1 | GPR174 | Probable G-protein coupled receptor 174 | T87661 | SEA |
| Q9UBY5 | LPAR3 | Lysophosphatidic acid receptor Edg-7 | T95923 | SEA |
| Q92633 | LPAR1 | Lysophosphatidic acid receptor Edg-2 | T92640 | SEA |
| Q99677 | LPAR4 | Lysophosphatidic acid receptor 4 | T58130 | SEA |
| Q9UJM8 | HAO1 | Hydroxyacid oxidase 1 | T63170 | SEA |
| Q9UP65 | PLA2G4C | Cytosolic phospholipase A2 gamma | T91113 | SEA |
| O95749 | GGPS1 | Geranyltranstransferase | T86528 | SEA |
| P40394 | ADH7 | Alcohol dehydrogenase class IV | T09770 | SEA |
| Q4U2R8 | SLC22A6 | Solute carrier family 22 member 6 (by homology) | T70680 | SEA |
| P37088 | SCNN1A | Amiloride-sensitive sodium channel | T52173 | SEA |
| O60603 | TLR2 | Toll-like receptor 2 | T82078 | SEA |
| O95749 | GGPS1 | Geranyltranstransferase | T86528 | SEA |
| Q9UMJ8 | GBA1 | Lysosomal acid glucosylceramidase | T63243 | SEA |
| TTD_ID | Disease_ID | Disease name | ICD_11 | Uniprot ID | Gene names |
|---|---|---|---|---|---|
| T65570 | DI0139 | Exposure to noxious substances harmful effect | [ICD-11: NE61] | P07327 | ADH1A |
| T20401 | DI0046 | Bacterial infection | [ICD-11: 1A00-1C4Z] | P00918 | CA2 |
| T20401 | DI0137 | Essential hypertension | [ICD-11: BA00] | P00918 | CA2 |
| T20401 | DI0166 | Glaucoma | [ICD-11: 9C61] | P00918 | CA2 |
| T20401 | DI0175 | Heart failure | [ICD-11: BD10-BD1Z] | P00918 | CA2 |
| T20401 | DI0214 | Insomnia | [ICD-11: 7A00-7A0Z] | P00918 | CA2 |
| T20401 | DI0372 | Seborrhoeic dermatitis | [ICD-11: EA81] | P00918 | CA2 |
| T70680 | DI0167 | Gout | [ICD-11: FA25] | Q4U2R8 | SLC22A6 |
| T70680 | DI0206 | Inborn purine/pyrimidine/nucleotide metabolism error | [ICD-11: 5C55] | Q4U2R8 | SLC22A6 |
| T70680 | DI0310 | Ocular disease | [ICD-11: N.A.] | Q4U2R8 | SLC22A6 |
| T19160 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P14555 | PLA2G2A |
| T31479 | DI0230 | Leishmaniasis | [ICD-11: 1F54] | P04054 | PLA2G1B |
| T31479 | DI0335 | Peroxisomal disease | [ICD-11: 5C57] | P04054 | PLA2G1B |
| T31479 | DI0367 | Rosacea | [ICD-11: ED90] | P04054 | PLA2G1B |
| T31479 | DI0398 | Synthesis disorder | [ICD-11: 5C52-5C59] | P04054 | PLA2G1B |
| T12808 | DI0279 | Muscular atrophy | [ICD-11: 8B61] | P17612 | PRKACA |
| T35734 | DI0086 | Chronic obstructive pulmonary disease | [ICD-11: CA22] | P34913 | EPHX2 |
| T35734 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | P34913 | EPHX2 |
| T76369 | DI0335 | Peroxisomal disease | [ICD-11: 5C57] | P23141 | CES1 |
| T76369 | DI0398 | Synthesis disorder | [ICD-11: 5C52-5C59] | P23141 | CES1 |
| T11754 | DI0101 | Corneal disease | [ICD-11: 9A76-9A78] | O00519 | FAAH |
| T83193 | DI0163 | General pain disorder | [ICD-11: 8E43] | Q8NER1 | TRPV1 |
| T06958 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P06746 | POLB |
| T79591 | DI0188 | Hyper-lipoproteinaemia | [ICD-11: 5C80] | P10827 | THRA |
| T79591 | DI0197 | Hypo-thyroidism | [ICD-11: 5A00] | P10827 | THRA |
| T98933 | DI0188 | Hyper-lipoproteinaemia | [ICD-11: 5C80] | P10828 | THRB |
| T58921 | DI0009 | Acute diabete complication | [ICD-11: 5A2Y] | P37231 | PPARG |
| T58921 | DI0025 | Alzheimer disease | [ICD-11: 8A20] | P37231 | PPARG |
| T58921 | DI0417 | Type 2 diabetes mellitus | [ICD-11: 5A11] | P37231 | PPARG |
| T53585 | DI0070 | Cardiovascular disease | [ICD-11: BA00-BE2Z] | P04035 | HMGCR |
| T53585 | DI0102 | Coronary atherosclerosis | [ICD-11: BA52] | P04035 | HMGCR |
| T53585 | DI0128 | Dyslipidemia | [ICD-11: 5C80-5C81] | P04035 | HMGCR |
| T53585 | DI0188 | Hyper-lipoproteinaemia | [ICD-11: 5C80] | P04035 | HMGCR |
| T53585 | DI0275 | Multiple sclerosis | [ICD-11: 8A40] | P04035 | HMGCR |
| T53585 | DI0287 | Myocardial infarction | [ICD-11: BA41-BA43] | P04035 | HMGCR |
| T53585 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | P04035 | HMGCR |
| T18664 | DI0163 | General pain disorder | [ICD-11: 8E43] | Q99685 | MGLL |
| T18664 | DI0409 | Tic disorder | [ICD-11: 8A05] | Q99685 | MGLL |
| T33489 | DI0022 | Allergic/hypersensitivity disorder | [ICD-11: 4A80-4A8Z] | P08842 | STS |
| T10965 | DI0088 | Circulatory system disease | [ICD-11: BE2Z] | P16109 | SELP |
| T10965 | DI0381 | Sickle-cell disorder | [ICD-11: 3A51] | P16109 | SELP |
| T50089 | DI0275 | Multiple sclerosis | [ICD-11: 8A40] | Q9H228 | S1PR5 |
| T13852 | DI0275 | Multiple sclerosis | [ICD-11: 8A40] | P21453 | S1PR1 |
| T13852 | DI0419 | Ulcerative colitis | [ICD-11: DD71] | P21453 | S1PR1 |
| T31989 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q9NRA0 | SPHK2 |
| T63512 | DI0199 | Idiopathic interstitial pneumonitis | [ICD-11: CB03] | Q13822 | ENPP2 |
| T11241 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | Q99500 | S1PR3 |
| T61657 | DI0225 | Kaposi sarcoma | [ICD-11: 2B57] | P10826 | RARB |
| T47888 | DI0419 | Ulcerative colitis | [ICD-11: DD71] | O95136 | S1PR2 |
| T95923 | DI0146 | Fibrosis | [ICD-11: GA14-GC01] | Q9UBY5 | LPAR3 |
| T95923 | DI0399 | Systemic sclerosis | [ICD-11: 4A42] | Q9UBY5 | LPAR3 |
| T92640 | DI0146 | Fibrosis | [ICD-11: GA14-GC01] | Q92633 | LPAR1 |
| T92640 | DI0199 | Idiopathic interstitial pneumonitis | [ICD-11: CB03] | Q92633 | LPAR1 |
| T92640 | DI0351 | Psoriasis | [ICD-11: EA90] | Q92633 | LPAR1 |
| T92640 | DI0399 | Systemic sclerosis | [ICD-11: 4A42] | Q92633 | LPAR1 |
| T63170 | DI0201 | Inborn carbohydrate metabolism error | [ICD-11: 5C51] | Q9UJM8 | HAO1 |
| T86528 | DI0057 | Bone paget disease | [ICD-11: FB85] | O95749 | GGPS1 |
| T86528 | DI0237 | Low bone mass disorder | [ICD-11: FB83] | O95749 | GGPS1 |
| T86528 | DI0267 | Mineral excesses | [ICD-11: 5B91] | O95749 | GGPS1 |
| T86528 | DI0281 | Musculoskeletal disorder | [ICD-11: FA00-FC0Z] | O95749 | GGPS1 |
| T70680 | DI0167 | Gout | [ICD-11: FA25] | Q4U2R8 | SLC22A6 |
| T70680 | DI0206 | Inborn purine/pyrimidine/nucleotide metabolism error | [ICD-11: 5C55] | Q4U2R8 | SLC22A6 |
| T70680 | DI0310 | Ocular disease | [ICD-11: N.A.] | Q4U2R8 | SLC22A6 |
| T52173 | DI0175 | Heart failure | [ICD-11: BD10-BD1Z] | P37088 | SCNN1A |
| T52173 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | P37088 | SCNN1A |
| T52173 | DI0311 | Oedema | [ICD-11: MG29] | P37088 | SCNN1A |
| T82078 | DI0346 | Prostate cancer | [ICD-11: 2C82] | O60603 | TLR2 |
| T86528 | DI0057 | Bone paget disease | [ICD-11: FB85] | O95749 | GGPS1 |
| T86528 | DI0237 | Low bone mass disorder | [ICD-11: FB83] | O95749 | GGPS1 |
| T86528 | DI0267 | Mineral excesses | [ICD-11: 5B91] | O95749 | GGPS1 |
| T86528 | DI0281 | Musculoskeletal disorder | [ICD-11: FA00-FC0Z] | O95749 | GGPS1 |
| T63243 | DI0242 | Lysosomal disease | [ICD-11: 5C56] | Q9UMJ8 | GBA1 |